Spokane doctor’s kidney treatment will be tested in 11000-person study – The Seattle Times

by

  1. Spokane doctor’s kidney treatment will be tested in 11000-person study The Seattle Times
  2. Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial The Lancet
  3. ‘On par with the biggest breakthroughs in medicine’: Spokane doctor discovers new kidney disease treatment. An 11000-person study will start in 2024 The Spokesman Review
  4. Significant benefit seen in Phase III trial of experimental drug for kidney disease Medical Xpress
  5. Kidney Disease Drug Candidate Shows Broad Inhibition of Damaging Hormone Inside Precision Medicine

Read original article here

Leave a Comment